Lee, J., Lee, S., Park, J., & Yoon, K. (2024). COSTAL CHONDROCYTE-DERIVED PELLET-TYPE AUTOLOGOUS CHONDROCYTE IMPLANTATION FOR TREATMENT OF ARTICULAR CARTILAGE DEFECT: A RANDOMIZED PHASE 3 CLINICAL TRIAL COMPARED TO MICROFRACTURE. Cytotherapy (Oxford, England), 26(6), e3. https://doi.org/10.1016/j.jcyt.2024.04.013
Chicago Style (17th ed.) CitationLee, J., S. Lee, J. Park, and K. Yoon. "COSTAL CHONDROCYTE-DERIVED PELLET-TYPE AUTOLOGOUS CHONDROCYTE IMPLANTATION FOR TREATMENT OF ARTICULAR CARTILAGE DEFECT: A RANDOMIZED PHASE 3 CLINICAL TRIAL COMPARED TO MICROFRACTURE." Cytotherapy (Oxford, England) 26, no. 6 (2024): e3. https://doi.org/10.1016/j.jcyt.2024.04.013.
MLA (9th ed.) CitationLee, J., et al. "COSTAL CHONDROCYTE-DERIVED PELLET-TYPE AUTOLOGOUS CHONDROCYTE IMPLANTATION FOR TREATMENT OF ARTICULAR CARTILAGE DEFECT: A RANDOMIZED PHASE 3 CLINICAL TRIAL COMPARED TO MICROFRACTURE." Cytotherapy (Oxford, England), vol. 26, no. 6, 2024, p. e3, https://doi.org/10.1016/j.jcyt.2024.04.013.